E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/27/2006 in the Prospect News Biotech Daily.

Kendle kept hold by Jefferies

Jefferies & Co., Inc. analyst David Windley maintained Kendle International Inc. at hold after the company's earnings per share of $0.29 missed Jefferies' estimate of $0.35 and consensus of $0.34. Kendle also reported $0.29 per share on $62.1 million in revenue, compared to the analyst's estimate of $0.35 on $60 million in revenue. Shares of the Cincinnati -based clinical research company were down $8.54, or 23.99%, at $27.06 on volume of 1,783,247 shares versus the three-month running average of 225,862 shares. (Nasdaq: KNDL)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.